Wences Chirino, T.; Rangel López, E.; Luna Angulo, A.; Carrillo Mora, P.; Landa Solis, C.; Samudio Cruz, M.A.; Fuentes Bello, A.C.; Paniagua Pérez, R.; RÃos MartÃnez, J.; Sánchez Chapul, L.
Crosstalk between Exercise-Derived Endocannabinoidome and Kynurenines: Potential Target Therapies for Obesity and Depression Symptoms. Pharmaceuticals 2023, 16, 1421.
https://doi.org/10.3390/ph16101421
AMA Style
Wences Chirino T, Rangel López E, Luna Angulo A, Carrillo Mora P, Landa Solis C, Samudio Cruz MA, Fuentes Bello AC, Paniagua Pérez R, RÃos MartÃnez J, Sánchez Chapul L.
Crosstalk between Exercise-Derived Endocannabinoidome and Kynurenines: Potential Target Therapies for Obesity and Depression Symptoms. Pharmaceuticals. 2023; 16(10):1421.
https://doi.org/10.3390/ph16101421
Chicago/Turabian Style
Wences Chirino, Tiffany, Edgar Rangel López, Alexandra Luna Angulo, Paul Carrillo Mora, Carlos Landa Solis, MarÃa Alejandra Samudio Cruz, Alim C. Fuentes Bello, Rogelio Paniagua Pérez, Juan RÃos MartÃnez, and Laura Sánchez Chapul.
2023. "Crosstalk between Exercise-Derived Endocannabinoidome and Kynurenines: Potential Target Therapies for Obesity and Depression Symptoms" Pharmaceuticals 16, no. 10: 1421.
https://doi.org/10.3390/ph16101421
APA Style
Wences Chirino, T., Rangel López, E., Luna Angulo, A., Carrillo Mora, P., Landa Solis, C., Samudio Cruz, M. A., Fuentes Bello, A. C., Paniagua Pérez, R., RÃos MartÃnez, J., & Sánchez Chapul, L.
(2023). Crosstalk between Exercise-Derived Endocannabinoidome and Kynurenines: Potential Target Therapies for Obesity and Depression Symptoms. Pharmaceuticals, 16(10), 1421.
https://doi.org/10.3390/ph16101421
